Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Cell & Gene Therapy
Manufacturing
J&J, Legend double CAR-T manufacturing investment to $500M
J&J and Legend will double investment in their Raritan, New Jersey, cell therapy manufacturing facility, bringing the total to $500 million.
Angus Liu
Oct 6, 2022 10:00am
Cytiva expansion tear continues with CEVEC Pharma acquisition
Oct 6, 2022 9:10am
Gilead's Kite wins all-clear for viral vector production
Oct 3, 2022 11:55am
'The Top Line': The Fierce 15, Fierce Biotech Summit highlights
Sep 30, 2022 6:00am
As Keytruda's shine wanes, can Merck build a 2nd blockbuster?
Sep 29, 2022 3:35pm
Bluebird's $3M gene therapy breaks drug price record
Sep 19, 2022 10:55am
More News
MeiraGTx shows off gene therapy manufacturing site in Ireland
Sep 19, 2022 8:50am
Under Biden's order, DOD and HHS earmark $1B for US boost
Sep 14, 2022 11:21am
'The Top Line': Sarepta's DMD trial, Illumina's Grail quest
Sep 9, 2022 6:00am
Lonza, Touchlight partner on 'doggybone DNA' development
Sep 6, 2022 9:05am
See more
